Expertise in
5
conditions

Zhanju M. Liu

No. 301 Yanchang Road, 
Shanghai, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
No. 301 Yanchang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Zhanju Liu practices in Shanghai, China. Liu is highly rated in 5 conditions, according to our data. Their top areas of expertise are Viral Gastroenteritis, Colitis, Hemorrhagic Proctocolitis, Hemorrhoidectomy, and Colonoscopy.

Their clinical research consists of co-authoring 177 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

No. 301 Yanchang Road, Shanghai, 200072, China
Other Locations
The Shanghai Tenth People's Hospital Chongming Branch, No. 66 Xiangyang East Road, Chongming, 202157, China
No. 301 Middle Yanchang Road, Shanghai, 200072, China
2 Jingba Road, Zhengzhou, 450014, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3

177 Total Publications

Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease.
Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease.
Journal: Gut microbes
Published: February 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile